SOLU-CORTEF (hydrocortisone sodium succinate) by Pfizer is clinical pharmacology glucocorticoids, naturally occurring and synthetic, are adrenocortical steroids that are readily absorbed from the gastrointestinal tract. First approved in 1955.
Drug data last refreshed 16h ago · AI intelligence enriched 22h ago
SOLU-CORTEF is an intravenous glucocorticoid (hydrocortisone sodium succinate) used for rapid delivery of high-dose corticosteroids in acute inflammatory and immunosuppressive conditions. It works by suppressing immune response and reducing inflammation across multiple organ systems. The water-soluble formulation allows immediate IV administration and achieves demonstrable effects within one hour.
Approaching loss of exclusivity signals defensive strategy focus; expect cost-containment and efficiency emphasis across commercial team.
CLINICAL PHARMACOLOGY Glucocorticoids, naturally occurring and synthetic, are adrenocortical steroids that are readily absorbed from the gastrointestinal tract. Naturally occurring glucocorticoids (hydrocortisone and cortisone), which also have salt-retaining properties, are used as replacement…
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Worked on SOLU-CORTEF at Pfizer? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Upgrade to Pro to access Medicare Part D spending data and other premium pharma intelligence.
Upgrade to Pro — $25/moUpgrade to Pro to access CMS Part B ASP pricing data and other premium pharma intelligence.
Upgrade to Pro — $25/moWorking on SOLU-CORTEF offers limited career growth potential given the LOE-approaching lifecycle and established generic competition. Roles focus on defending formulary position, managing relationships with hospital systems, and cost optimization rather than market expansion or innovation.